Magnetic sphincter augmentation better than PPIs for intractable GERD
M3 Global Newsdesk Sep 10, 2018
Among patients with gastroesophageal reflux disease (GERD), nearly 90% who underwent laparoscopic magnetic sphincter augmentation (MSA) reported relief of regurgitation, compared with 10% of patients on twice-daily proton pump inhibitors (PPIs), according to a new study in Gastrointestinal Endoscopy.
“Treating GERD surgically corrects the sphincter defects and significantly reduces the number of reflux events, rather than merely reducing the acidity of the refluxate,” wrote...
To read this article Sign up / Login for free
- Stay on top of policy changes & daily news that matter to you as a healthcare professional
- Update yourself with quick summaries from reputed journals in your specialty
- Earn from paid surveys and influence new developments in healthcare
- Participate in daily quizzes to improve skills and compete with peers
- Save yourself time, as we bring you these and more useful features all at one place!
You get a FREE lifetime membership, with a simple one-time sign up process!